Formulation and Delivery Technologies for mRNA Vaccines

86Citations
Citations of this article
446Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

mRNA vaccines have become a versatile technology for the prevention of infectious diseases and the treatment of cancers. In the vaccination process, mRNA formulation and delivery strategies facilitate effective expression and presentation of antigens, and immune stimulation. mRNA vaccines have been delivered in various formats: encapsulation by delivery carriers, such as lipid nanoparticles, polymers, peptides, free mRNA in solution, and ex vivo through dendritic cells. Appropriate delivery materials and formulation methods often boost the vaccine efficacy which is also influenced by the selection of a proper administration route. Co-delivery of multiple mRNAs enables synergistic effects and further enhances immunity in some cases. In this chapter, we overview the recent progress and existing challenges in the formulation and delivery technologies of mRNA vaccines with perspectives for future development.

Cite

CITATION STYLE

APA

Zeng, C., Zhang, C., Walker, P. G., & Dong, Y. (2022). Formulation and Delivery Technologies for mRNA Vaccines. In Current Topics in Microbiology and Immunology (Vol. 440, pp. 71–110). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/82_2020_217

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free